Bauke Anninga

age:

38 years

appointments:

3 active

0 prior

primary industry:

Scientific research and development

about Bauke

Since 2022, Dr Anninga has been a director of 3 companies, the current directorship have a combined turnover of approximately £2.2m.

Combined Valuation

£47.6m

Combined Turnover

£2.2m

active directorships over time

company
turnover
valuation
start
end
status
role
nucleome therapeutics limited£156.1k£42.3mOct 2022-OpenDirector
nanosyrinx ltd£546.3k£4.4mMay 2022-OpenDirector
outrun therapeutics limited£1.5m£858.4kNov 2023-OpenDirector